FDA-Cleared Bed Linens Engineered to Reduce Development of Pressure Ulcers

DermaTherapy® Bed Linens by Standard Textile are the first and only bedding medical device that reduces the likelihood of patients developing pressure ulcers.

News provided by

Standard Textile

Sep 19, 2016, 06:45 ET

CINCINNATI, Sept. 16, 2016 /PRNewswire/ -- No other preventable hospital complication occurs as frequently as pressure ulcers. In fact, patients who experience pressure ulcers are more likely to die during their hospital stay and are more likely to be readmitted to the hospital after discharge.

While there are currently hundreds of products on the market to address pressure ulcers, the solution needs to be comprehensive—similar to the change in the standards of hospital hygiene more than 100 years ago.

With two U.S. patents (US 7,816,288 and US 8,283,267) and two pending patents, the DermaTherapy(R) system is comprised of a pillowcase, top flat sheet, bottom fitted sheet and underpad, all developed in partnership between Standard Textile Co., Inc. and Precision Fabrics Group. DermaTherapy is a registered trademark of Precision Fabrics Group, Inc.

Healthcare systems currently spend billions of dollars attempting to prevent pressure ulcers, but little attention is paid to the items with which patients have the most contact: hospital bed linens.

DermaTherapy® bedding technology was specifically developed to create a new generation of healthcare bedding that reduces the overall occurrence of pressure ulcers. Its silk-like fibers help regulate the patient's "microclimate"—a combination of heat, moisture, pressure, friction, and shear. Conventional hospital bedding often generates excessive moisture, friction and shear, while generating lint and airborne particles—all potentially hazardous to patients.

DermaTherapy® has already been used extensively in clinical trials throughout the country, and the results are highly encouraging. One large Midwestern university medical center saved $1.5 million and reduced patients' length of stay, due in large part to a reduction of hospital-acquired pressure ulcers.

"Our system-wide conversion to DermaTherapy® bedding has dramatically improved the quality of care for our Cone Health patients and delivered significant savings for our healthcare system from the reduction of pressure ulcers," said Annette Osborne MSN, RN, NEA-BC, Vice President, Nursing and Patient Services at Cone Health, Greensboro, NC.

Standard Textile is working to introduce its product to as many hospitals and care facilities as possible. The recent FDA clearance will add momentum to this effort, while making the American public aware of a potentially life-saving device they might have never considered.

For more information on DermaTherapy®, visit DermaTherapy.StandardTextile.com.

Contact: Alon Vanterpool, Public Relations Manager, Bouvier Kelly
For DermaTherapy®
(mobile) 336-639-9368
[email protected]

Photo - http://photos.prnewswire.com/prnh/20160916/408730

SOURCE Standard Textile